ReviewFrontiers in oncology2019

Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.

Miren Taberna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.